1.Effects of IVIG on allogenic skin graft in an HLA-A2 pre-sensitized mouse model
Yao HE ; Yujun CHEN ; Wensheng HUANG ; Lishou XIONG ; Baili CHEN
Journal of Chinese Physician 2010;(z1):15-18
Objective To investigate the effect of IVIG on pre-existing anti-HLA-A2 Ab levels and graft skin survival.Methods C57BL/6 wild type mice were sensitized to HLA-A2 by intraperitoneal injec-tion (IP) of HLA-A2 TgN mouse spleen cells (C57BL/6-TgN [HLA-2.1]1Enge SC) expressing human HLA-A2 at day 0, week 3 and 4.Sensitized mice were respectively treated with human IVIG , albumin, gly-cine, or PBS for 5 days during week 7.Skin transplantation from TgN mice to C57BL/6 wild type mice was performed at week 10 .Efficacy of IVIG DES was assessed by measuring anti-HLA Ab levels by ELISA pre-/post-Rx and graft skin survival was monitored daily post-Tx.Results Changes of HLA-A2-IgG levels:IgG HLA-A2 class I Ab levels in all groups predictably increased from baseline following spleen cell IP and peaked at week 4 ( P <0.01 ) , indicating sensitization .IVIG-treated mice showed significantly lower IgG Ab levels vs.albumin, glycine and PBS-treated at week 9 post-desensitization ( P <0.01).IgG quickly increased to extremely high levels in all groups following skin transplantation ( P <0.01 ) .Graft skin sur-vival between Rx-groups were similar with all rejecting at about 7 days post-transplantation ( P >0.05 ) . Conclusion However, IVIG alone does not inhibit anti-HLA class I Ab production after skin transplanta-tion or prolong SG survival , indicating combination of IVIG with other immunosuppressant or more optimal protocol for desensitization might show more efficacy and should be under explored .
2.Analysis of 102 ADR Cases Occurred from 2005 to 2007 in Our Hospital
Baili XIONG ; Xiaoxia HE ; Zhongping CHAI ; Maoping TIAN
China Pharmacy 2005;0(23):-
OBJECTIVE:To investigate the characteristics of adverse drug reactions(ADR)occurrred in our hospital.METHODS:102 ADR cases collected from 2005 to 2007 in our hospital were analyzed in respect of the patients' age and sex,route of administration,drug species and clinical manifestation etc.RESULTS:In 102 ADR cases,67(65.69%)were female,92(90.20%)were induced by intravenous drop infusion,86(84.31%)were related to anti-infectives,and 76 cases(74.51%)manifested as lesion of skin and its appendants.CONCLUSION:ADR monitor work should be strengthened to avoid or reduce the incidence of ADR.
3.Safety and efficacy of single balloon enteroscopy for small intestinal disorders
Baili CHEN ; Lishou XIONG ; Xiang GAO ; Jinhui WANG ; Ning ZHANG ; Yi CUI
Chinese Journal of Digestive Endoscopy 2011;28(3):134-137
Objective To evaluate safety and clinical significance of single balloon enteroscopy (SBE) for small intestinal diseases. Methods Data of 83 patients with suspected or known small intestinal diseases, who underwent SBE from March 2009 to July 2010, were reviewed in terms of preparation time,procedure time, detection rate and complication occurrence. Results The 83 patients included 37 cases of digestive tract bleeding, 38 chronic abdominal pain, 1 chronic diarrhea, 2 fever and 5 incomplete ileus. A total of 94 procedures of SBE were performed, including oral route in 46 patients, anal route in 26 and both routes in 11. Excluding 6 cases with endoscopic therapy, the mean procedure time of oral approach was 29.6 ± 10. 3 min, and that of anal route was 57.1 ± 15.6 min. Abnormalities were detected in 57 ( 68.7% )of the 83 patients, with detection rate of 81.1% (30/37) in digestive tract bleeding with unknown reason,57. 8% (22/38) in chronic abdominal pain of unknown reason, 50. 0% (1/2) in fever of unknown reason and 80. 0% (4/5) in incomplete ileus. Peutz-Jeghers syndrome was diagnosed in 6 patients and endoscopic polypectomy was performed, with complicated bleeding in one patient. No other procedure-related complications were observed. Conclusion SBE is well-tolerated and safe for diagnosis of small intestine diseases,with easy manipulatiou, short procedure time, high detection rate and satisfactory location of intestinal hemorrhagic lesions.
4.Transparent cap-fitted endoscopy in diagnosis of Barrett's esophagus
Pingguang LEI ; Baili CHEN ; Yi CUI ; Xiaoying NIE ; Jinping WANG ; Lishou XIONG ; Jinhui WANG
Chinese Journal of Digestive Endoscopy 2009;26(4):191-193
Objective To evaluate the feasibility of transparent cap-fitted endoscopy in improving diagnostic yield of Barrett's esophagus(BE).Methods A total of 168 patients with endoscopieally suspected BE were randomly divided into cap group(n=60)and control group(n=108).A transparent cap-fitted endoscopy Was applied in cap group to take biopsy,while a routine one was used in control group,and 2 biopsies from suspected lesions were collected in each patient.BE was diagnosed in the presence of columnar epithelium and the diagnostic rate was compared between 2 groups.Results The diagnostic rates of BE were 83.3%(50/60)and 69.4%(75/108)in cap and control group,respectively(P<0.05).Conclusion The lesions at cardia Call be exposed clearly with capped endoscopy,which facilitates localized biopsy and BE diagnosis.